| |
| |
|
| Insider
Information: |
Flynn Karen |
| Relationship: |
|
| City: |
Lionville |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
113,719 |
|
|
Indirect Shares
|
1,550 |
|
|
| Direct
Value |
$10,354,418 |
|
|
|
Indirect Value
|
$558,667 |
|
|
| Total
Shares |
115,269 |
|
|
| Total
Value |
$10,913,084 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
West Pharmaceutical Services Inc |
WST |
|
2019-02-19 |
23,692 |
2017-12-01 |
1,550 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2019-12-05 |
39,283 |
2016-12-16 |
0 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
24,339 |
2020-01-08 |
0 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2024-01-02 |
26,405 |
2022-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QTRX |
Quanterix Corp |
|
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,947 |
26,405 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2023-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,993 |
24,339 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$11,805 |
D/D |
9,001 |
23,458 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,149 |
17,346 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2022-10-03 |
4 |
A |
$10.48 |
$11,172 |
D/D |
1,066 |
14,457 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-09-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,952 |
|
% |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
245 |
13,197 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2022-07-01 |
4 |
A |
$16.79 |
$2,754 |
D/D |
164 |
13,391 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Chief Commercial Officer |
• – – |
2022-01-10 |
4 |
AS |
$116.64 |
$288,334 |
D/D |
(2,472) |
33,223 |
0 |
% |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,151 |
35,695 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-01-11 |
4 |
AS |
$112.14 |
$278,279 |
D/D |
(2,478) |
34,544 |
0 |
% |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-01-04 |
4 |
AS |
$104.42 |
$10,338 |
D/D |
(99) |
37,022 |
0 |
% |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,476 |
37,121 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-04-09 |
4 |
A |
$56.46 |
$20,269 |
D/D |
359 |
35,645 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,286 |
35,286 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,071 |
39,283 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,955 |
28,212 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2019-02-19 |
4 |
A |
$102.51 |
$215,168 |
D/D |
2,099 |
23,692 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-08-07 |
4 |
S |
$116.23 |
$2,377,833 |
D/D |
(20,458) |
21,593 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-08-07 |
4 |
OE |
$21.22 |
$477,294 |
D/D |
20,458 |
42,051 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,274 |
20,257 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,183 |
6,983 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-02-13 |
4 |
A |
$93.00 |
$359,910 |
D/D |
3,870 |
21,593 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-12-29 |
4 |
A |
$98.67 |
$738 |
D/D |
7 |
17,723 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-12-01 |
4 |
A |
$99.11 |
$738 |
I/I |
7 |
1,298 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
